Cite

HARVARD Citation

    Shenoy, G. et al. (2021). Preclinical evaluation of cancer immune therapy using patient‐derived tumor antigen‐specific T cells in a novel xenograft platform. Clinical & translational immunology. 10 (2), p. n/a. [Online]. 
  
Back to record